Effect of aqueous extract from Phaseolus vulgaris pods on cytokine profile of streptozotocin-induced diabetic rats

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 6, Issue 1, 2015, Pages 1511-1520

  Kyznetsova, M Y ^a   Lavrovska, D O ^b   Zhyvolozhnyi, A Y ^a   Dovgusha, O V ^a   Halenova, T I ^a   Savchuk, O M ^a   Ostapchenko, L I ^a  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b Medical Center 'Boris'   (Ukraine)

Author keywords

Cytokines; Extract; Phaseolus vulgaris; Streptozotocin induced diabetes

Indexed keywords

CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN G; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; PHASEOLUS VULGARIS EXTRACT; PLANT EXTRACT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; NONHUMAN; PHASEOLUS VULGARIS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

PHASEOLUS VULGARIS; RATTUS;

EID: 84921525848     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. J Diabetes Metab Disord 2012; 11(1): 1-8.
2. Ichinose K, Kawasaki E, Eguchi K. Am J Nephrol 2007; 27(6): 554-564.
3. Christen U, von Herrath MG. Immunol Res 2004; 30(3): 309-325.
4. Pearl-Yafe M, Kaminitz A, Yolcu ES, Yaniv I, Stein J, Askenasy N. Curr Pharm Des 2007; 13: 749-760.
5. Mehmeti I, Gurgul-Convey E, Lenzen S, Lortz S. Biochim Biophys Acta 2011; 1813(10): 1827-1835.
6. Suarez-Pinzon WL, Rabinovitch A. Int J Exp Diabetes Res 2001; 2(1): 3-17.
7. Barrett ML, Udani JK. Nutr J 2011; 10: 24.
8. Luka CD, Olatunde A, Tijjani H, Olisa-Enewe IA. IJSIT 2013; 2(4): 292-301
9. Helmstädter A. J Med Food 2010; 13(2): 251-254.
10. Venkateswaran S, Pari L. Asia Pac J Clin Nutr 2002; 11(3): 206-209.
11. Zafar M, Naqvi S. Int J Morphol 2010; 28 (1): 135-142.
12. Hernández-Saavedra D, Mendoza-Sánchez M, Hernández-Montiel HL, Guzmán-Maldonado HS, Loarca-Piña GF, Salgado LM, Reynoso-Camacho R. Plant Foods Hum Nutr 2013; 68 (2): 207-212.
13. Crowther JR. The ELISA Guidebook. Totowa, New Jersey: Humana Press Inc., 2001, pp. 436.
14. Bradford MM. Analyt Biochem 1976; 72: 248-254.
15. Pari L, Venkateswaran S. Pharmazie 2003; 58: 916-919.
16. Lenze S. Diabetologia 2008; 51: 216-226.
17. Szkudelski T. Physiol Res 2001; 50: 536-546.
18. Usuelli V, La Rocca E. Pharmacol Res. 2014; 10: 1016.
19. Soliman A, De Sanctis V, Yassin M, Elalaily R, Almawashi H. Diabetes Metab 2014; 5:10.
20. Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Hubert M. Ann NY Acad Sci 2013; 1281: 16-35.
21. Espinoza-Jiménez A, Peón AN, Terrazas LI. Mediators Inflamm 2012; 10:1155
22. Haroun M, El-Sayed MM. J Clin Biochem Nutr 2007; 40: 56-61.
23. Lieberman SM, DiLorenzo TP. Tissue Antigens 2003; 62: 359-377.
24. Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L. Diabetes Care 1999; 8: 1347-1353.
25. Almawi WY, Tamim H, Azar ST. J Clin Endocrinol Metab 1999; 84: 1497-502.
26. Rabinovitch A, Suarez-Pinzon WL. Rev Endocr Metab Disord 2003; 4: 291-299.
27. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Diabetes 2006; 55: 774-779.
28. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D, Glaser N, et al. Diabetes 2007; 56: 2790-2796.
29. Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G. Diabetes Care 2001; 24: 956-957.
30. Mohamed-Ali V, Armstrong L, Clarke D, Bolton CH, Pinkney JH. J Intern Med 2001; 250: 415-421.